Order Article Reprints

Roy C, Adam JP, Morin F, Lemieux-Blanchard É, Doucet S, Friedmann D, Belisle A, Charpentier D. Azacitidine-Induced Pyoderma Gangrenosum at Injection Sites in a Patient with Myelodysplastic Syndrome. Current Oncology. 2018; 25(1):103-105. https://doi.org/10.3747/co.25.3779

Roy, C., J.P. Adam, F. Morin, É. Lemieux-Blanchard, S. Doucet, D. Friedmann, A. Belisle, and D. Charpentier. 2018. "Azacitidine-Induced Pyoderma Gangrenosum at Injection Sites in a Patient with Myelodysplastic Syndrome" Current Oncology 25, no. 1: 103-105. https://doi.org/10.3747/co.25.3779

Roy, C., Adam, J. P., Morin, F., Lemieux-Blanchard, É., Doucet, S., Friedmann, D., Belisle, A., & Charpentier, D. (2018). Azacitidine-Induced Pyoderma Gangrenosum at Injection Sites in a Patient with Myelodysplastic Syndrome. Current Oncology, 25(1), 103-105. https://doi.org/10.3747/co.25.3779